Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2eac0de123a146101fedee0fe13042a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba3b945769e008c450b35f127c2951c1 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C61-13 |
filingDate |
1992-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1997-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_184a0bc51ed0cbc785f0b07774e47a59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeb40c9a4ab2584778e4c5b92e4c0678 |
publicationDate |
1997-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2091366-C1 |
titleOfInvention |
Bicyclo (2,2,2) octane-2-carboxylic acid sodium salt having anticonvulsion activity |
abstract |
FIELD: medicine, more particularly as antiepileptic agent. SUBSTANCE: claimed compound of formula: . Reagent 1: bicyclo (2,2,2) octane-2-carboxylic acid. Reagent 2: sodium base. EFFECT: improved properties. 1 dwg, 1 tbl |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2396002-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2396002-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9923056-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106309418-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2673887-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102300573-A |
priorityDate |
1992-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |